Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 12/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.41 |
| ▸ | TGM2 | P21980 | 1/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.40 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.40 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.40 |
| ▸ | KRAS | P01116 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20326954 | 0.93 | STING1 (0.47) | STING1NT5E | |
| SCHEMBL20324534 | 0.93 | STING1 (0.47) | STING1NT5E | |
| SCHEMBL20326932 | 0.89 | STING1 (0.49) | STING1NT5EPOLBFUT5TGM2 | |
| SCHEMBL20324916 | 0.87 | STING1 (0.49) | STING1NT5EPOLBFUT5TGM2 | |
| SCHEMBL23476786 | 0.86 | STING1 (0.46) | STING1 | |
| SCHEMBL22352078 | 0.86 | RNASEL (0.52) | NT5E | |
| SCHEMBL20324726 | 0.85 | FUT5 (0.38) | STING1NT5EPOLBFUT5TGM2 | |
| SCHEMBL20326986 | 0.83 | STING1 (0.44) | STING1NT5EPOLBFUT5TGM2 | |
| SCHEMBL22083250 | 0.83 | STING1 (0.49) | STING1NT5EPOLBFUT5TGM2 | |
| SCHEMBL23476832 | 0.83 | NT5E (0.48) | STING1NT5EFUT5TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018118665-A1 | CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT | MERCK SHARP & DOHME CORP. (US) | 2018-06-28 | — | — | WO | disclosed |